J 2002

Symptomatic Intravenous Antipyretic Therapy: Efficacy of Metamizol, Diclofenac, and Propacetamol

OBOŘILOVÁ, Andrea, Jiří MAYER, Zdeněk POSPÍŠIL and Zdeněk KOŘÍSTEK

Basic information

Original name

Symptomatic Intravenous Antipyretic Therapy: Efficacy of Metamizol, Diclofenac, and Propacetamol

Authors

OBOŘILOVÁ, Andrea (203 Czech Republic, guarantor), Jiří MAYER (203 Czech Republic), Zdeněk POSPÍŠIL (203 Czech Republic) and Zdeněk KOŘÍSTEK (203 Czech Republic)

Edition

Journal of Pain and Symptom Management, New York, Elsevier, 2002, 0885-3924

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30200 3.2 Clinical medicine

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 2.466

RIV identification code

RIV/00216224:14310/02:00007643

Organization unit

Faculty of Science

UT WoS

000180146400009

Keywords in English

Diclofenac; metamizol; propacetamol; fever; febrile neutropenia
Změněno: 22/6/2009 16:29, prof. RNDr. Zdeněk Pospíšil, Dr.

Abstract

V originále

In order to support symptomatic fewer therapy, the non-randomized pilot study deals with the patients' discomfort accompanying fever and the beneficial effects of the symptomatic fever management.

Links

MSM 143100001, plan (intention)
Name: Funkcionální diferenciální rovnice a matematicko-statistické modely
Investor: Ministry of Education, Youth and Sports of the CR, Functional-differential equations and mathematical-statistical models